PDS Biotechnology Corp (PDSB) stock is higher by 608.70% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PDSB stock a score of 71 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 94. PDSB's rank also includes a fundamental score of 88. In addition to the average rating from Wall Street analysts, PDSB stock has a mean target price of 19.25. This means analysts expect the stock to add 96.83% over the next 12 months. The short-term technical score for PDSB is 29.
What's Happening with PDSB Stock Today
PDS Biotechnology Corp (PDSB) stock is up 6.3% while the S&P 500 is higher by 0.01% as of 9:44 AM on Wednesday, Jun 16. PDSB is higher by $0.58 from the previous closing price of $9.20 on volume of 65,911 shares. Over the past year the S&P 500 is higher by 35.92% while PDSB is higher by 608.70%. PDSB lost -$0.71 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on PDS Biotechnology Corp (PDSB) Stock.
